Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
71 Cards in this Set
- Front
- Back
What is the key site (pathway) for NADPH and ribose-5-phosphate synthesis?
|
PPP
|
|
Why are reducing equivalents produced in PPP important to RBCs?
|
they defend against O2 toxicity
|
|
What is the PPP also referred to as?
|
the hexose monophosphate shunt
|
|
Is the PPP unidirectional?
|
no, 5 -> 6 and back again
|
|
What other positive aspects are there in th PPP?
|
reducing equivalents (NADPH)
|
|
What two things make NADPH production a good thing?
|
a) biosynthesis of fatty acids b) prevent oxidative damage
|
|
What role does NADPH drug detoxification?
|
NADPH is required in drug detoxification
|
|
Are ingested alternate sugars used in the glycolytic pathways?
|
No, they are broken down. If needed they are resynthesized from glucose.
|
|
How can galactose enter the glycolytic pathway?
|
converted to glycogen or G-1-P (which can be converted to G-6-P)
|
|
PPP occur in tissue that require high amounts of reducing equivalents (NADPH), which three organs are these?
|
liver, mammary glands, the adrenal cortex
|
|
What perctage of glucose oxidation is done by PPP in adipose tissue? Why is this percentage so high?
|
a) 50% b) fatty acid biosynthesis occurs there
|
|
What is the first stage of the PPP?
|
Oxidative
|
|
Which branch of the PPP produces reducing equivalents?
|
the first (oxidative)
|
|
Is the oxidative rxn of the PPP revesible?
|
No
|
|
What happens in the first branch of the PPP?
|
G-6-P is converted to ribulose-5-phosphate
|
|
What does the non-oxidative branch of the pathway do?
|
Converts pentose sugars back into 6 carbon sugars
|
|
Is the non-oxidative branch of the PPP reversible?
|
yes
|
|
What is glucose-6-phosphate dehydrognenase? How is it inhibited?
|
It converts G-6-P to Ribulose-5-P in the oxidative part of the PPP... b) Feedback (product) Excess NADPH
|
|
What is the branch point for the oxidative part of the PPP?
|
G-6-P
|
|
What inhibits oxidative PPP branch?
|
product inhibition (NADPH)
|
|
What effect does a high insulin to glucagon ratio have on the oxidative branch of the PPP?
|
positive regulation
|
|
What effect does a high insulin to glucagon ratio have on G-6-P dehydrogenase? And it's Vmax?
|
a) increases synthesis b) increased Vmax (its capacity)
|
|
Where is the gene for G-6-P dehydrogenase, which plays a key role in PPP?
|
X-chromosome
|
|
When would an individual with a defect in G6PD experience difficulty?
|
during oxidative stress, since defects in G6PD are sensitive to oxidants
|
|
What is one clinical manifestation of a defect in G6PD?
|
hemolytic anemia due to RBC destruction
|
|
Do most mutation in G6PD cause symptoms?
|
No
|
|
What is the biochemical reason for the vulnerability of G6PD deficient individuals?
|
G6PD (defective) > no NADPH > no reduction of Glutathione thus it cannot cycle between reductase and peroxidase forms > no removal of reactive oxygen species (ROS produced in healthy individuals too), nor hydrogen and lipid peroxides.
|
|
Which form of glutathione deals with radicals?
|
glutathione peroxidase
|
|
What food can cause oxidative stress?
|
fava beans
|
|
What do oxidants cause?
|
crosslinking of hemoglobin, called Heinz bodies, which can cause cell lysing and difficulty passing through capilaries
|
|
Which branch of the PPP is referred to as the transketolase reaction?
|
non-oxidative
|
|
What are the 5-carbon sugars converted to in the transketolase reaction?
|
F-6-P and Glyceraldehyde-3-P
|
|
What do the transketolase reaction, pyruvate dehydrogenase reaction, and the ∂-ketoglutarate dehydrogenase reactions require?
|
Thiamine pyrophosphate as a cofactor
|
|
What is good way to assess a thiamine deficiency?
|
check transketolase activity
|
|
What is thiamine deficiency associated with?
|
alcohol consumption
|
|
Because thiamine is turned over quickly how do deficiencies present?
|
short periods of time over several weeks
|
|
What are the short term symptoms of thiamine deficiency?
|
appetite loss, nausea, depression, and fatigue over a short period of time.
|
|
What are the chronic symptoms of thiamine deficiency?
|
mental confusion, unsteadiness, loss of eye coordination and congestive heart failure (Wernicke-Korsakoff syndrome)
|
|
Which measurement can be used to diagnose thiamine deficiency?
|
Transketolase
|
|
What does a severe deficiency of thiamine cause and what is it known as?
|
Beriberi, neuromuscular symptoms, including muscular atrophy and weakness.
|
|
What is the significance of UDP Glucose? How is it formed?
|
a) Its an activated sugar with a higher energy level, b) it is formed by the
|
|
What must happen to the glucose prior to conversion to lactose?
|
It must first be converted to a higher energy state call UDP-galactose
|
|
Which enzyme converts UDP-glucose to UDP-galactose?
|
Epimerase
|
|
What is the linkage configuration of lactose?
|
ß-1-4 linkage
|
|
What is the enzyme that converts UDP-galactose to Lactose?
|
Lactose synthase (works with ∂-lactalbumin)
|
|
What is alpha lactalbumin?
|
a protein that is released after childbirth, in response to prolactin, that modulates the Km by about 1000 times
|
|
In the fructose pathway, what is the first step and which enzyme catatlyzes this step?
|
Fructose to F-1-P, fructokinase
|
|
What are the second and third steps in the fructose pathway? And what is the enzyme that catalyzes this process?
|
a) F-1-P to dehhydroxyacetone-P to glyceraldehyde-3-P (or vice versa), b) aldolase-B, c) triose kinase
|
|
Which enzyme toggle between dehhydroxyacetone-P and glyceraldehyde-3-P
|
triose kinase
|
|
Besides F-1-P, which other substrate can aldolase B (in the liver) metabolize?
|
F-1,6-BisP
|
|
Which substrate does aldolase have a lower Km, F-1-P or F-1,6-BisP?
|
F-1,6-BisP
|
|
What is the rate limiting step in fructose metabolism?
|
F-1-P to dehhydroxyacetone-P or glyceraldehyde-3-P
|
|
In terms of enzymes, why will fructose-1,6-BisP only be metabolized in the liver?
|
Aldolase-A, found in the muscle, can only metabolize F-1,6-BisP, while the liver can also metabolize F-1-P
|
|
What are the adverse effects of a fructokinase deficiency?
|
none… it's benign… fructose is just excreted
|
|
What are the adverse effects of a deficiency in aldolase B?
|
the accumulation of F-1-P inhibits glycogenolysis and gluconeogenesis
|
|
What pH imbalance does the inhibition of gluconeogenesis cause?
|
lactic acidosis
|
|
What function does aldolase B serve in Glucose synthesis?
|
it synthesizes glucose from G-3-P and DHAP
|
|
What effect does F-1-P have on aldolase, with respect to glucose synthesis
|
it depresses aldolase B already low activity
|
|
What effect does the accumulation F-1-P have on cellular phospate?
|
it depletes cellular phosphate, due to rapid ATP hydrolysis of fructokinase.
|
|
What effect does low phosphate have on cells?
|
low phosphate activate AMP deaminase… amp-> IMP-> uric acid, which leads to depletion of adenine nucleotides… thus ATP synthesis is limited
|
|
What are the two steps in galactose metabolism that leads to the glucose-1-P and ultimately G-6-P? and their enzymes?
|
a) Galactose to galactose-1-P (enzyme is galactokinase + ATP) and b) Galactose-1-P to glucose-1-P (enzyme = uridylytransferase also known as GALT)
|
|
In the second step of galactose metabolism how do you derive G-1-P?
|
galactose-1-P + UDP glucose -> G-1-P + UDP galactose
|
|
What role does epimerase play?
|
UDP galactose -> UDP glucose
|
|
In general which is more serious galactose enzyme deficiencies or frutose deficiencies?
|
Galactose, but the scheme is the same, i.e., GALT is worse than galactokinase.
|
|
Which part of galactose metabolism is a deficiency referred to as non-classical? Which is classical?
|
a) non-classical deficiency is part one, which involves galacokinase… b) classical deficiency is part two which involves GALT
|
|
How do you treat non-classcal deficency?
|
remove galactose and lactose (lactose = glucose and galactose)
|
|
What is a consequence of galactosemia? How does this occur?
|
Juvinile cataracts… b) via conversion of galactose to galactitol via aldose reductase in polyol pathway.
|
|
Why does galactitol only occur when galactose is actually ingested?
|
Because Km for aldose reductase is high and thus affinity is low, unless galactose is in high quantity.
|
|
What is the problem with the GALT deficiency?
|
Galactose-1-P is an inhibitor of UDP-glucose pyrophosphorylase, which is a key enzyme in the breakdown of glycogen
|
|
What are the manifestations of a GALT deficiency?
|
failure to thrive, mental retardation, jaundice and liver disease
|
|
How is GALT activity measured?
|
blood test
|